TipRanks
Kura Oncology (DE:KUR)
FRANKFURT:KUR
Germany Market
KUR
Kura Oncology
RESEARCH TOOLSreports

Kura Oncology (KUR) Ratios

8 Followers

Kura Oncology Ratios

DE:KUR's free cash flow for Q2 2026 was $0.99. For the 2026 fiscal year, DE:KUR's free cash flow was decreased by $ and operating cash flow was $-3.26. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 4.73 6.06 9.46 12.26 18.56
Quick Ratio
 4.71 6.05 9.46 12.26 18.56
Cash Ratio
 0.59 1.27 2.85 1.06 2.15
Solvency Ratio
 -0.54 -0.49 -0.50 -2.94 -3.75
Operating Cash Flow Ratio
 -0.95 -0.55 1.71 -3.54 -4.58
Short-Term Operating Cash Flow Coverage
 -26.50 0.00 51.52 0.00 0.00
Net Current Asset Value
$ 20.08M$ 144.44M$ 398.31M$ 380.82M$ 410.40M
Leverage Ratios
Debt-to-Assets Ratio
 0.04 0.03 0.02 0.04 0.03
Debt-to-Equity Ratio
 0.50 0.12 0.04 0.04 0.03
Debt-to-Capital Ratio
 0.34 0.11 0.04 0.04 0.03
Long-Term Debt-to-Capital Ratio
 0.10 0.05 0.02 0.02 0.02
Financial Leverage Ratio
 12.14 4.24 1.84 1.13 1.09
Debt Service Coverage Ratio
 -51.88 -182.62 -40.59 -96.99 -588.87
Interest Coverage Ratio
 -224.01 -200.81 -119.33 -107.04 -610.76
Debt to Market Cap
 <0.01 0.01 0.01 <0.01 0.01
Interest Debt Per Share
 0.29 0.25 0.21 0.26 0.21
Net Debt to EBITDA
 0.16 0.47 1.23 0.13 0.28
Profitability Margins
Gross Profit Margin
94.73%99.92%100.00%0.00%0.00%
EBIT Margin
-382.86%-410.27%-316.14%0.00%0.00%
EBITDA Margin
-378.60%-408.74%-314.57%0.00%0.00%
Operating Profit Margin
-411.90%-449.94%-358.55%0.00%0.00%
Pretax Profit Margin
-384.19%-412.51%-319.15%0.00%0.00%
Net Profit Margin
-384.30%-412.95%-322.89%0.00%0.00%
Continuous Operations Profit Margin
-384.30%-412.95%-322.89%0.00%0.00%
Net Income Per EBT
100.03%100.11%101.17%100.00%100.00%
EBT Per EBIT
93.27%91.68%89.01%92.06%97.12%
Return on Assets (ROA)
-50.49%-37.74%-22.89%-34.00%-29.77%
Return on Equity (ROE)
-207.18%-160.03%-42.06%-38.42%-32.32%
Return on Capital Employed (ROCE)
-67.74%-48.86%-28.35%-40.08%-32.36%
Return on Invested Capital (ROIC)
-66.95%-48.76%-28.17%-39.94%-32.18%
Return on Tangible Assets
-50.49%-37.74%-22.89%-34.00%-29.77%
Earnings Yield
-28.47%-30.59%-23.18%-14.49%-16.34%
Efficiency Ratios
Receivables Turnover
 8.18 5.35 0.00 0.00 0.00
Payables Turnover
 1.70 0.01 0.00 0.37 0.00
Inventory Turnover
 1.64 0.14 0.00 0.00 0.00
Fixed Asset Turnover
 5.28 4.45 7.20 0.00 0.00
Asset Turnover
 0.13 0.09 0.07 0.00 0.00
Working Capital Turnover Ratio
 0.16 0.11 0.10 0.00 0.00
Cash Conversion Cycle
 52.98 -29.41K 0.00 -988.81 0.00
Days of Sales Outstanding
 44.65 68.17 0.00 0.00 0.00
Days of Inventory Outstanding
 222.75 2.64K 0.00 0.00 0.00
Days of Payables Outstanding
 214.41 32.13K 0.00 988.81 0.00
Operating Cycle
 267.39 2.71K 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.26 -0.73 1.56 -1.70 -1.64
Free Cash Flow Per Share
 -1.32 -0.81 1.55 -1.71 -1.65
CapEx Per Share
 0.06 0.08 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.05 1.10 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -19.70 -9.65 284.57 -743.00 -175.82
Capital Expenditure Coverage Ratio
 -19.70 -9.65 284.57 -743.00 -175.82
Operating Cash Flow Coverage Ratio
 -4.57 -3.13 8.09 -7.26 -7.85
Operating Cash Flow to Sales Ratio
 -1.45 -0.95 2.49 0.00 0.00
Free Cash Flow Yield
-11.28%-7.76%17.84%-11.87%-13.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.48 -3.27 -4.31 -6.90 -6.12
Price-to-Sales (P/S) Ratio
 13.48 13.50 13.93 0.00 0.00
Price-to-Book (P/B) Ratio
 21.52 5.23 1.81 2.65 1.98
Price-to-Free Cash Flow (P/FCF) Ratio
 -8.87 -12.89 5.61 -8.42 -7.51
Price-to-Operating Cash Flow Ratio
 -9.33 -14.22 5.59 -8.44 -7.55
Price-to-Earnings Growth (PEG) Ratio
 0.09 -0.06 1.49 -2.80 -2.01
Price-to-Fair Value
 21.52 5.23 1.81 2.65 1.98
Enterprise Value Multiple
 -3.40 -2.84 -3.20 -6.88 -5.88
Enterprise Value
 995.54M 782.31M 542.59M 1.03B 793.57M
EV to EBITDA
 -3.40 -2.84 -3.20 -6.88 -5.88
EV to Sales
 12.89 11.59 10.07 0.00 0.00
EV to Free Cash Flow
 -8.48 -11.07 4.05 -8.26 -7.17
EV to Operating Cash Flow
 -8.91 -12.21 4.04 -8.27 -7.21
Tangible Book Value Per Share
 0.55 1.99 4.80 5.43 6.27
Shareholders’ Equity Per Share
 0.55 1.99 4.80 5.43 6.27
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 -0.01 0.00 0.00
Revenue Per Share
 0.87 0.77 0.63 0.00 0.00
Net Income Per Share
 -3.34 -3.18 -2.02 -2.08 -2.03
Tax Burden
 1.00 1.00 1.01 1.00 1.00
Interest Burden
 1.00 1.01 1.01 1.01 1.00
Research & Development to Revenue
 3.36 3.72 3.15 0.00 0.00
SG&A to Revenue
 1.75 1.78 1.43 0.00 0.00
Stock-Based Compensation to Revenue
 0.50 0.55 0.63 0.00 0.00
Income Quality
 0.38 0.23 -0.77 0.82 0.81
Currency in USD